Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

[1]  S. Holland.  Cytokine therapeutics in infectious diseases , 2001 .

[2]  H. Okamura,et al.  IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner , 2000, Gut.

[3]  W. Paul,et al.  IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6 , 2000, Nature Immunology.

[4]  H. Okamura,et al.  Skin-Specific Caspase-1-Transgenic Mice Show Cutaneous Apoptosis and Pre-Endotoxin Shock Condition with a High Serum Level of IL-181 , 2000, The Journal of Immunology.

[5]  H. Okamura,et al.  Elevated interleukin (IL)‐18 levels during acute graft‐versus‐host disease after allogeneic bone marrow transplantation , 2000, British journal of haematology.

[6]  S. Akira,et al.  Genetically Resistant Mice Lacking IL-18 Gene Develop Th1 Response and Control Cutaneous Leishmania major Infection1 , 2000, The Journal of Immunology.

[7]  S. Akira,et al.  Potentiality of Interleukin-18 as a Useful Reagent for Treatment and Prevention of Leishmania major Infection , 2000, Infection and Immunity.

[8]  John T. Chang,et al.  The costimulatory effect of IL‐18 on the induction of antigen‐specific IFN‐γ production by resting T cells is IL‐12 dependent and is mediated by up‐regulation of the IL‐12 receptor β2 subunit , 2000, European journal of immunology.

[9]  H. Tsutsui,et al.  Pathophysiological roles of interleukin‐18 in inflammatory liver diseases , 2000, Immunological reviews.

[10]  M. Kurimoto,et al.  IFN-γ-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12 , 2000, The Journal of Immunology.

[11]  L. Morrison,et al.  A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response1 , 2000, The Journal of Immunology.

[12]  M. Kurimoto,et al.  IFN-γ-Inducing Factor (IL-18) Increases Allergic Sensitization, Serum IgE, Th2 Cytokines, and Airway Eosinophilia in a Mouse Model of Allergic Asthma1 , 2000, The Journal of Immunology.

[13]  M. Kurimoto,et al.  Antitumor Activity of Interleukin-18 on Mouse Glioma Cells , 2000, Journal of immunotherapy.

[14]  T. Tanimoto,et al.  Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. , 2000, Journal of pediatric surgery.

[15]  L. Joosten,et al.  Neutralization of IL-18 Reduces Neutrophil Tissue Accumulation and Protects Mice Against Lethal Escherichia coli and Salmonella typhimurium Endotoxemia1 , 2000, The Journal of Immunology.

[16]  G. Fantuzzi,et al.  IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Fantuzzi,et al.  Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Okamura,et al.  IL-12 synergizes with IL-18 or IL-1β for IFN-γ production from human T cells , 2000 .

[19]  Y. Mahida.  The key role of macrophages in the immunopathogenesis of inflammatory bowel disease , 2000 .

[20]  M Eisenstein,et al.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Akira,et al.  The role of IL-18 in innate immunity. , 2000, Current opinion in immunology.

[22]  Q. Myrvik,et al.  Oral Administration of Chitin Down-Regulates Serum IgE Levels and Lung Eosinophilia in the Allergic Mouse1 , 2000, The Journal of Immunology.

[23]  G. Del Sero,et al.  NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. , 2000, Gastroenterology.

[24]  C. David,et al.  Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice. , 2000, Current opinion in immunology.

[25]  Hiroshi Yamamoto,et al.  Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells , 2000, Cancer Gene Therapy.

[26]  G. McCaughan,et al.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection , 2000, Gut.

[27]  H. Mühl,et al.  Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. , 2000, Biochemical and biophysical research communications.

[28]  G. Fantuzzi,et al.  IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Hill,et al.  The p55 TNF-α Receptor Plays a Critical Role in T Cell Alloreactivity1 , 2000, The Journal of Immunology.

[30]  R. Strieter,et al.  Differential Roles of IL-18 in Allergic Airway Disease: Induction of Eotaxin by Resident Cell Populations Exacerbates Eosinophil Accumulation1 , 2000, The Journal of Immunology.

[31]  L. Wen,et al.  In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes , 2000, The Journal of experimental medicine.

[32]  R. Sartor.  Colitis in HLA-B27/β2 Microglobulin Transgenic Rats , 2000 .

[33]  S. Matsuda,et al.  Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-γ Production by Dendritic Cells1 , 2000, The Journal of Immunology.

[34]  M. Kurimoto,et al.  Antitumor Effects on Mouse Melanoma Elicited by Local Secretion of Interleukin-12 and Their Enhancement by Treatment with Interleukin-18 , 1998, Cancer Investigation.

[35]  G. Berry,et al.  Vaccination with Heat-Killed Listeria as Adjuvant Reverses Established Allergen-Induced Airway Hyperreactivity and Inflammation: Role of CD8+ T Cells and IL-181 , 2000, The Journal of Immunology.

[36]  M. Micallef,et al.  Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration , 1999, Cancer Gene Therapy.

[37]  S. Akira,et al.  IL-18 deficiency selectively enhances allergen-induced eosinophilia in mice. , 2000, The Journal of allergy and clinical immunology.

[38]  M. Filippi,et al.  Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study , 1999, Journal of neurology, neurosurgery, and psychiatry.

[39]  M. Kurimoto,et al.  Interleukin‐18 acts as an angiogenesis and tumor suppressor , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  C. Janeway,et al.  Insulin-dependent diabetes mellitus and its animal models. , 1999, Current opinion in immunology.

[41]  S. Akira,et al.  IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Dayer,et al.  Interleukin-18, rheumatoid arthritis, and tissue destruction. , 1999, The Journal of clinical investigation.

[43]  I. McInnes,et al.  A proinflammatory role for IL-18 in rheumatoid arthritis. , 1999, The Journal of clinical investigation.

[44]  S. Akira,et al.  The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function , 1999, The Journal of experimental medicine.

[45]  D. Mahvi,et al.  Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Chan,et al.  Kinetics of interferon‐γ secretion and its regulatory factors in the early phase of acute graft‐versus‐host disease , 1999, Immunology.

[47]  J. Wilcox,et al.  Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. , 1999, The Journal of investigative dermatology.

[48]  Y. Luo,et al.  Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin. , 1999, Journal of immunology.

[49]  B. Moss,et al.  IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Okamura,et al.  Interleukin-18 enhances antigen-induced eosinophil recruitment into the mouse airways. , 1999, American journal of respiratory and critical care medicine.

[51]  H. Okamura,et al.  Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells. , 1999, Anticancer research.

[52]  S. Akira,et al.  Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. , 1999, Immunity.

[53]  M. Sugaya,et al.  Interleukins 18 and 12 synergistically upregulate interferon-gamma production by murine dendritic epidermal T cells. , 1999, The Journal of investigative dermatology.

[54]  M. Sweet,et al.  Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. , 1999, Journal of immunology.

[55]  M. Su,et al.  Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. , 1999, Journal of immunology.

[56]  H. Mühl,et al.  Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. , 1999, The Journal of investigative dermatology.

[57]  M. Kurimoto,et al.  Airway epithelium expresses interleukin-18. , 1999, The European respiratory journal.

[58]  M. Micallef,et al.  Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model , 1999, Cancer Immunology, Immunotherapy.

[59]  B. Torbett,et al.  Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. , 1999, Journal of immunology.

[60]  H. Okamura,et al.  Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. , 1999, Journal of immunology.

[61]  A. Cooke,et al.  Interleukin-13 prevents autoimmune diabetes in NOD mice. , 1999, Diabetes.

[62]  H. Kolb,et al.  IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. , 1999, Journal of immunology.

[63]  J. Pelletier,et al.  Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18. , 1999, Arthritis and rheumatism.

[64]  S. Wasserman,et al.  Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. , 1999, Journal of immunology.

[65]  H. Okamura,et al.  Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. , 1999, Journal of immunology.

[66]  A. Fusco,et al.  Bioactive IL-18 expression is up-regulated in Crohn's disease. , 1999, Journal of immunology.

[67]  J. Pelletier.  The influence of tissue cross-talking on OA progression: role of nonsteroidal antiinflammatory drugs. , 1999, Osteoarthritis and cartilage.

[68]  R. Hock,et al.  Neuroblastoma cells expressing mature IL-18, but not proIL-18, induce a strong and immediate antitumor immune response. , 1999, Journal of immunotherapy.

[69]  B. Bohle,et al.  Oligodeoxynucleotides containing CpG motifs induce IL‐12, IL‐18 and IFN‐γ production in cells from allergic individuals and inhibit IgE synthesis in vitro , 1999, European journal of immunology.

[70]  B. Piqueras,et al.  Modulation of interleukin‐18 expression in human colon carcinoma: Consequences for tumor immune surveillance , 1999, International journal of cancer.

[71]  H. Weiner,et al.  CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  V. Taneja,et al.  HLA class II transgenic mice as models of human diseases , 1999, Immunological reviews.

[73]  A. Suri,et al.  Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice , 1999, Immunological reviews.

[74]  C. Janeway,et al.  Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis , 1999, Immunological reviews.

[75]  M. Ikeda,et al.  An Essential Role for NF-κB in IL-18-Induced IFN-γ Expression in KG-1 Cells , 1999, The Journal of Immunology.

[76]  M. Prinz,et al.  Murine Microglial Cells Produce and Respond to Interleukin‐18 , 1999, Journal of neurochemistry.

[77]  S. Akira,et al.  Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. , 1999, Journal of immunology.

[78]  H. Young,et al.  IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. , 1999, Journal of immunology.

[79]  H. Okamura,et al.  Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18) , 1999, Gene Therapy.

[80]  F. Wong,et al.  Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. , 1999, Journal of immunology.

[81]  H. Okamura,et al.  Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. , 1999, Cellular immunology.

[82]  T. Joh,et al.  Cultures of astrocytes and microglia express interleukin 18. , 1999, Brain research. Molecular brain research.

[83]  J. Katz,et al.  In Autoimmune Diabetes the Transition from Benign to Pernicious Insulitis Requires an Islet Cell Response to Tumor Necrosis Factor α , 1999, The Journal of experimental medicine.

[84]  Crafford A. Harris,et al.  Defective Interleukin (IL)-18–mediated Natural Killer and T Helper Cell Type 1 Responses in IL-1 Receptor–associated Kinase (IRAK)-deficient Mice , 1999, The Journal of experimental medicine.

[85]  T. Tanimoto,et al.  Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. , 1999, Journal of immunology.

[86]  G. Fantuzzi,et al.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[87]  M. Ikeda,et al.  Interleukin-18 Protects Mice against Acute Herpes Simplex Virus Type 1 Infection , 1999, Journal of Virology.

[88]  S. Akira,et al.  IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. , 1999, International immunology.

[89]  K. Okumura,et al.  Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. , 1999, Journal of immunology.

[90]  T. Tanimoto,et al.  Cloning and expression of interleukin‐18 binding protein , 1999, FEBS letters.

[91]  H. Okamura,et al.  Combined effects of IL‐12 and IL‐18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans , 1999, European journal of immunology.

[92]  W. Ouyang,et al.  Induction of interferon‐γ production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation , 1999 .

[93]  S. Akira,et al.  IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. , 1999, Journal of immunology.

[94]  M. Lotz,et al.  IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. , 1999, Journal of immunology.

[95]  K. Ozato,et al.  Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-gamma. , 1999, Journal of immunology.

[96]  C. Benoist,et al.  Cellular and molecular changes accompanying the progression from insulitis to diabetes , 1999, European journal of immunology.

[97]  C. Moskaluk,et al.  IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. , 1998, Journal of immunology.

[98]  T. Yoshimoto.  Interleukin-18 (IL-18), although anti-allergic when administered with IL-12, stimulates IL-4 and histamine release by basophils , 1999 .

[99]  C. Dinarello.  IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. , 1999, The Journal of allergy and clinical immunology.

[100]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.

[101]  H. Mcdevitt,et al.  The role of MHC class II molecules in susceptibility and resistance to autoimmunity. , 1998, Current opinion in immunology.

[102]  S. Youssef,et al.  Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[103]  M. Mcduffie.  Genetics of autoimmune diabetes in animal models. , 1998, Current opinion in immunology.

[104]  J. Sims,et al.  Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[105]  T. Born,et al.  Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling* , 1998, The Journal of Biological Chemistry.

[106]  H. Kleinman,et al.  Tumor-associated macrophages as targets for cancer therapy. , 1998, Journal of the National Cancer Institute.

[107]  K. Torigoe,et al.  Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. , 1998, Cellular immunology.

[108]  M. Kool,et al.  Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. , 1998, Journal of immunology.

[109]  S. Nagata,et al.  Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand , 1998, Nature Medicine.

[110]  I. McInnes,et al.  Selective Expression and Functions of Interleukin 18 Receptor on T Helper (Th) Type 1 but not Th2 Cells , 1998, The Journal of experimental medicine.

[111]  T. Billiar,et al.  Nitric Oxide Prevents IL-1β and IFN-γ-Inducing Factor (IL-18) Release from Macrophages by Inhibiting Caspase-1 (IL-1β-Converting Enzyme) , 1998, The Journal of Immunology.

[112]  H. Okamura,et al.  Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. , 1998, Journal of immunology.

[113]  M. Kurimoto,et al.  Direct Activation of Human CD8+ Cytotoxic T Lymphocytes by Interleukin‐18 , 1998, Japanese journal of cancer research : Gann.

[114]  S. Akira,et al.  IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. , 1998, Journal of immunology.

[115]  T. Griffith,et al.  TRAIL: a molecule with multiple receptors and control mechanisms. , 1998, Current opinion in immunology.

[116]  A. Enk,et al.  Production of functional IL‐18 by different subtypes of murine and human dendritic cells (DC): DC‐derived IL‐18 enhances IL‐12‐dependent Th1 development , 1998, European journal of immunology.

[117]  W. Mehal,et al.  IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. , 1998, Journal of immunology.

[118]  H. Okamura,et al.  LPS-Stimulated SJL Macrophages Produce IL-12 and IL-18 That Inhibit IgE Production In Vitro by Induction of IFN-γ Production from CD3intIL-2Rβ+ T Cells , 1998, The Journal of Immunology.

[119]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[120]  N. Rothwell,et al.  Cloning of rat brain interleukin-18 cDNA , 1998, Molecular Psychiatry.

[121]  M Kurimoto,et al.  Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. , 1998, Journal of immunology.

[122]  Klaus Eichmann,et al.  Murine Macrophages Secrete Interferon γ upon Combined Stimulation with Interleukin (IL)-12 and IL-18: A Novel Pathway of Autocrine Macrophage Activation , 1998, The Journal of experimental medicine.

[123]  H. Okamura,et al.  Regulation of interferon-γ production by IL-12 and IL-18 , 1998 .

[124]  M Tomura,et al.  A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells. , 1998, Journal of immunology.

[125]  N. Horwood,et al.  Interleukin-18: perspectives on the newest interleukin. , 1998, Cytokine & growth factor reviews.

[126]  M. Neurath,et al.  Cutting Edge: IL-12 and IL-18 Differentially Regulate the Transcriptional Activity of the Human IFN-γ Promoter in Primary CD4+ T Lymphocytes , 1998, The Journal of Immunology.

[127]  D. Godfrey,et al.  α/β–T Cell Receptor (TCR)+CD4−CD8− (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10 , 1998, The Journal of experimental medicine.

[128]  K. Murphy,et al.  T lymphocyte differentiation in the periphery. , 1998, Current opinion in immunology.

[129]  G. Fantuzzi,et al.  Interleukin-18 Regulation of Interferon γ Production and Cell Proliferation as Shown in Interleukin-1β–Converting Enzyme (Caspase-1)-Deficient Mice , 1998 .

[130]  G. Trinchieri,et al.  Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. , 1998, The Journal of clinical investigation.

[131]  M. Ikeda,et al.  Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. , 1998, Biochemical and biophysical research communications.

[132]  S. Akira,et al.  Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.

[133]  Junying Yuan,et al.  Murine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE , 1998, Cell.

[134]  H. Okamura,et al.  IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. , 1998, Journal of immunology.

[135]  M. Su,et al.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.

[136]  H. Okamura,et al.  Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. , 1998, The Journal of clinical investigation.

[137]  C. Belka,et al.  Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial Cells , 1998 .

[138]  C. Bogdan,et al.  Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite , 1998 .

[139]  T. Martin,et al.  Interleukins in the control of osteoclast differentiation. , 1998, Critical reviews in eukaryotic gene expression.

[140]  J. Heesemann,et al.  IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. , 1998, Journal of immunology.

[141]  H. Okamura,et al.  Interleukin-18: a novel cytokine that augments both innate and acquired immunity. , 1998, Advances in immunology.

[142]  H. Waldmann,et al.  Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. , 1997, Journal of immunology.

[143]  C. Benoist,et al.  Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[144]  H. Okamura,et al.  IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. , 1997, Journal of immunology.

[145]  A. Sica,et al.  Interaction of NF-κB and NFAT with the Interferon-γ Promoter* , 1997, The Journal of Biological Chemistry.

[146]  R. Kastelein,et al.  Comparison of the effects of interleukin‐1α, interleukin‐lβ and interferon‐γ‐inducing factor on the production of interferon‐γ by natural killer , 1997 .

[147]  H. Okamura,et al.  IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. , 1997, Journal of immunology.

[148]  T. Tanimoto,et al.  Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. , 1997, Cancer research.

[149]  K. Torigoe,et al.  Purification and Characterization of the Human Interleukin-18 Receptor* , 1997, The Journal of Biological Chemistry.

[150]  S. Targan,et al.  A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .

[151]  R. Kastelein,et al.  IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκB , 1997 .

[152]  M. Kai,et al.  Decreased expression of cytokines that induce type 1 helper T cell/interferon-gamma responses in genetically susceptible mice infected with Mycobacterium avium. , 1997, Clinical immunology and immunopathology.

[153]  H. Okamura,et al.  A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. , 1997, Journal of immunology.

[154]  H. Okamura,et al.  Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells , 1997, Infection and immunity.

[155]  M. Ikeda,et al.  Interleukin-18 induces activation and association of p56(lck) and MAPK in a murine TH1 clone. , 1997, Biochemical and biophysical research communications.

[156]  J. Bradley,et al.  Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. , 1997, Journal of immunology.

[157]  M. Ikeda,et al.  Immunohistochemical and immuno-electron-microscopic detection of interferon-γ-inducing factor (”interleukin-18”) in mouse intestinal epithelial cells , 1997, Cell and Tissue Research.

[158]  A. Enk,et al.  Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. , 1997, Journal of immunology.

[159]  H. Okamura,et al.  Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. , 1997, Journal of immunology.

[160]  M. Kurimoto,et al.  Interleukin-18 Activates NF-κB in Murine T Helper Type 1 Cells , 1997 .

[161]  H. Okamura,et al.  Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[162]  E. Petricoin,et al.  Phosphorylation Events Modulate the Ability of Interferon Consensus Sequence Binding Protein to Interact with Interferon Regulatory Factors and to Bind DNA* , 1997, The Journal of Biological Chemistry.

[163]  R. Kamen,et al.  Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production , 1997, Nature.

[164]  G. Morrone,et al.  Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. , 1997, Gastroenterology.

[165]  H. Okamura,et al.  Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. , 1997 .

[166]  S. Nagata,et al.  Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. , 1997, Journal of immunology.

[167]  F. Annunziato,et al.  Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. , 1997, The American journal of pathology.

[168]  M Kurimoto,et al.  IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. , 1997, Journal of immunology.

[169]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[170]  T. Tanimoto,et al.  In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites , 1997, Cancer Immunology, Immunotherapy.

[171]  H. Kolb,et al.  Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. , 1997, The Journal of clinical investigation.

[172]  T. Joh,et al.  Induction of Interferon-γ Inducing Factor in the Adrenal Cortex* , 1997, The Journal of Biological Chemistry.

[173]  M. Su,et al.  Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme , 1997, Science.

[174]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[175]  H. Okamura,et al.  IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. , 1996, Journal of immunology.

[176]  H. Okamura,et al.  Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. , 1996, Cellular immunology.

[177]  T. Hoey,et al.  Cooperative DNA Binding and Sequence-Selective Recognition Conferred by the STAT Amino-Terminal Domain , 1996, Science.

[178]  Yoshimasa Tanaka,et al.  Interferon-γ-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-γ-inducing factor in macrophages elicited by allografted tumor cells , 1996 .

[179]  M. Kaplan,et al.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.

[180]  T. Tanimoto,et al.  Interferon‐γ‐inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin‐12 for interferon‐γ production , 1996 .

[181]  M. Leach,et al.  T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice , 1996, The Journal of experimental medicine.

[182]  H. Okamura,et al.  Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. , 1996, Journal of immunology.

[183]  A. Sher,et al.  Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. , 1996, Journal of immunology.

[184]  L Steinman,et al.  Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.

[185]  D. Carvajal,et al.  IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .

[186]  L. Adorini,et al.  IL-12: a key cytokine in immune regulation. , 1996, Immunology today.

[187]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[188]  A. H. Drummond,et al.  Fas ligand in human serum , 1996, Nature Medicine.

[189]  S. Dower,et al.  IL-1Rrp Is a Novel Receptor-like Molecule Similar to the Type I Interleukin-1 Receptor and Its Homologues T1/ST2 and IL-1R AcP (*) , 1996, The Journal of Biological Chemistry.

[190]  R. Kastelein,et al.  A newly defined interleukin-1? , 1996, Nature.

[191]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.

[192]  R. Zinkernagel,et al.  Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.

[193]  A. Billiau,et al.  Interferon-gamma: biology and role in pathogenesis. , 1996, Advances in immunology.

[194]  W. Krenger,et al.  Graft-versus-host disease and the Th1/Th2 paradigm , 1996, Immunologic research.

[195]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[196]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.

[197]  J. Weidner,et al.  The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy , 1995, The Journal of experimental medicine.

[198]  Antonio Celada,et al.  Repression of I-Aβ Gene Expression by the Transcription Factor PU.1 (*) , 1995, The Journal of Biological Chemistry.

[199]  H. Okamura,et al.  A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock , 1995, Infection and immunity.

[200]  S. Szabo,et al.  Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. , 1995, Immunity.

[201]  P. Ramage,et al.  Expression, Refolding, and Autocatalytic Proteolytic Processing of the Interleukin-1-converting Enzyme Precursor (*) , 1995, The Journal of Biological Chemistry.

[202]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[203]  R. Shackelford,et al.  IFN-gamma and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. , 1995, Journal of immunology.

[204]  J. Leonard,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 , 1995, The Journal of experimental medicine.

[205]  G. Trinchieri.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[206]  F. Finkelman,et al.  IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. , 1994, Journal of immunology.

[207]  Susumu Tonegawa,et al.  High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice , 1994, Cell.

[208]  C. Glass,et al.  Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif , 1994, Molecular and cellular biology.

[209]  M. Ernst,et al.  Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo , 1994, Clinical and experimental immunology.

[210]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[211]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[212]  K. Meyer zum Büschenfelde,et al.  Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. , 1993, Blood.

[213]  R. Black,et al.  Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.

[214]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.

[215]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[216]  R. Coffman,et al.  Regulation of immunity to parasites by T cells and T cell-derived cytokines. , 1992, Annual review of immunology.

[217]  R. Black,et al.  Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. , 1991, The Journal of clinical investigation.

[218]  T. Olsson,et al.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.

[219]  G. Shearer,et al.  T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. , 1988, Immunology today.

[220]  D. Cosman.  Control of messenger RNA stability. , 1987, Immunology today.